Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASBP | AZN | AMGN | GILD | VRTX |
| Company | Aspire Biopharma Holdings Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1102 | 90.37 | 321.21 | 122.00 | 454.28 |
| High | 0.1102 | 91.73 | 325.51 | 122.98 | 455.62 |
| Low | 0.0955 | 90.12 | 319.06 | 119.73 | 449.48 |
| Latest | 0.1080 | 91.56 | 324.36 | 119.71 | 455.72 |
| Change | +0.0130 | +1.73 | +6.62 | +0.10 | +3.68 |
| % Change | +13.68% | +1.93% | +2.08% | +0.08% | +0.81% |
| Volume | 64,055,457 | 4,657,485 | 2,471,932 | 3,739,983 | 770,172 |
| 20-Day Average Volume | 34,172,746 | 5,704,285 | 2,807,753 | 6,895,063 | 1,361,432 |
| Previous Close | 0.0950 | 89.83 | 317.74 | 119.61 | 452.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0973 | 90.72 | 333.44 | 123.97 | 438.52 |
| 20-Day Raw Stochastic | 67.17% | 55.58% | 36.65% | 12.95% | 79.94% |
| 20-Day Relative Strength | 37.56 | 59.29 | 52.05 | 46.70 | 60.29 |
| Weighted Alpha | -90.04 | +42.69 | +23.23 | +26.21 | +13.71 |
| Today's Opinion | 88% Sell | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.25% since 12/08/25 | +0.27% since 12/08/25 | +1.13% since 12/08/25 | -0.93% since 12/08/25 | +2.88% since 12/08/25 |
| Low | 0.0709 on 12/10/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 0.1144 on 12/12/25 | 91.66 on 12/10/25 | 324.87 on 12/15/25 | 123.74 on 12/11/25 | 456.00 on 12/12/25 |
| 1-Month | |||||
| %Chg | +0.38% since 11/14/25 | +2.72% since 11/14/25 | -3.53% since 11/14/25 | -3.97% since 11/14/25 | +4.03% since 11/14/25 |
| Low | 0.0709 on 12/10/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 0.1242 on 11/18/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -74.10% since 09/15/25 | +17.26% since 09/15/25 | +18.38% since 09/15/25 | +6.68% since 09/15/25 | +15.65% since 09/15/25 |
| Low | 0.0709 on 12/10/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.4691 on 10/30/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -70.81% since 06/13/25 | +22.98% since 06/13/25 | +10.03% since 06/13/25 | +9.17% since 06/13/25 | -0.15% since 06/13/25 |
| Low | 0.0709 on 12/10/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 0.8753 on 08/18/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,210 | 278,601,088 | 171,096,960 | 149,377,888 | 114,691,136 |
| Shares Outstanding, K | 107,477 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -12,540,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -1,850,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.86 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 11/14/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/06/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.76 | 14.51 | 15.04 | 29.13 |